A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2

Clinical trial NCT04999111 · COMPLETED

Trial details

NCT number: NCT04999111
Sponsor: Janssen Vaccines & Prevention B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease

Start date: 2021-08-06
Primary completion: 2021-10-27
Enrollment: 1541

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.